Morgan Stanley Trims Earnings Estimates for BUD APAC, Keeps Overweight Rating and HK$9 Target

Stock News
Feb 16

Morgan Stanley has incorporated BUD APAC's 2025 results and 2026 guidance into its forecasts. The firm has lowered its profit estimates for the company for the current and next fiscal years by 12% and 14%, respectively. Morgan Stanley introduced an earnings per share forecast of 6 cents for BUD APAC for 2028. It maintained an "Overweight" rating on the stock and extended its valuation base to 2026, keeping the target price at HK$9.

Due to an increased proportion of at-home consumption channels in China, the firm has reduced its average selling price forecast for 2026-2027 by 2% to 3%. This adjustment led to a decrease in the gross margin forecast for 2026 and 2027 by 1.1 and 2 percentage points, respectively. Morgan Stanley also raised its forecast for the sales, general, and administrative expense ratio, reflecting investments related to the channel shift in China and commercial investments in eastern and western regions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10